Intellectual Property India Publishes Patent Application for 'Method For Selective Screening Of Imipramine Using Eu3+ Ion-Doped Cr2ctx Mxene Qds' Filed by Sardar Vallabhbhai National Institute Of Technology

MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202621030724 A) filed by Sardar Vallabhbhai National Institute Of Technology, Surat, Gujarat, on March 13, for 'method for selective screening of imipramine using eu3+ ion-doped cr2ctx mxene qds.'

Inventor(s) include Suresh Kumar Kailasa; Pooja Dharni Dhar Singh; and Z. V. P. Murthy.

The application for the patent was published on May 1, under issue no. 18/2026.

According to the abstract released by the Intellectual Property India: "Disclosed method (100) for selective screening of the antidepressant drug Imipramine (IMP) using Eu3+ ion-doped Cr2CTx MXene QDs comprising exfoliating Cr2AlC MAX phase to produce Cr2CTx MXene QDs by selective etching of A...